research Imiquimod
Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.
Search
for
Sort by
Research
600-630 / 1000+ results research Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: A randomized, double-blinded, placebo-controlled trial
Eflornithine cream makes laser hair removal more effective for treating pseudofolliculitis barbae.
research (135) Post-Finasteride Syndrome: A Case Presentation and Discussion
research Diffuus haaruitval door telogeen effluvium
research Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review
Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.
research Telogen effluvium: Pathogenesis, clinical features, diagnosis, and management
Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.
research Latanoprost
A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.
research Telogen Effluvium as a complication of scalp reconstruction with tissue expander: a case report.
A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.
research Eflúvio telógeno pós-infecção por Covid-19: uma revisão narrativa / Telogen effluvium post Covid-19 infection: a narrative review
COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.
research HAIRY PREGNANCY
A woman's increased hair growth during pregnancy due to PCOS resolved after delivery.
research Pregnancy and Skin
Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.
research Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease
A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.
research Das idiopathische chronische Telogeneffluvium der Frau
Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.
research Eosinophilic pustular folliculitis (Ofuji’s disease) without macroscopic pustules
EPF can occur without visible pustules.
research Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection
Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.
research ACUTE TELOGEN EFFLUVIUM: A SEQUELA OF COVID-19 INFECTION
COVID-19 can cause temporary hair loss.
research Postmenopausal Frontal Fibrosing Alopecia
Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.
research Net Study - A clinical study of skin changes in pregnancy
Pregnant women often experience various skin changes, with pigment changes and stretch marks being most common.
research A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center
Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.
research A cross-sectional study of cutaneous changes during pregnancy in a tertiary care hospital in Northern India
Pregnant women often experience skin changes, so proper care is needed.
research An Ode to Telogen Effluvium
The poem ends by asking for case reports on serious health issues like Telogen Effluvium.
research A case of telogen effluvium associated with drug-induced hyperprolactinemia.
A woman's temporary hair loss was caused by high prolactin levels from her medication.
research CARACTERÍSTICAS CLÍNICAS DO EFLÚVIO TELÓGENO INDUZIDO PELA INFECÇÃO DE COVID-19: REVISÃO INTEGRATIVA
COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.
research Bullous impetigo and pregnancy: Case report and review of blistering conditions in pregnancy
Pregnant women with blisters should be checked for bullous impetigo.
research Evaluation of a Therapeutic Alternative for Telogen Effluvium: A Pilot Study
The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.
research Clinico-Epidemiological Aspects of Telogen Effluvium In Iraqi Women
Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.
research Telogen effluvium revisited.
Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.
research Clinico-Epidemiological Aspects of Telogen Effluvium In Iraqi Women
Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.
research Ex-Vivo Evaluation of Eflornitine Hydrochloride Loaded Solid Lipid Microparticles Based Cream
The EFH-SLM cream is more effective and gentler for treating excessive hair growth in women.
research Telogen effluvium: a sequela of COVID‐19
COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.